LiteWell provides physician‑supervised hormone replacement therapy (HRT) for women experiencing symptoms related to perimenopause, menopause, and hormonal imbalance. Our approach is flexible and includes both convenience clinics and remote care (telemedicine) to maximize access, efficiency, and continuity of care.
We do not offer one‑size‑fits‑all hormone protocols, symptom‑only prescribing, or short‑term fixes. Every plan is individualized, clinically guided, and grounded in measurable data and ongoing monitoring.
Hormonal changes are a normal part of aging, particularly during perimenopause and menopause. However, the symptoms associated with these transitions are not always inevitable or something women must simply tolerate.
Fluctuations in estrogen, progesterone, and other hormones can affect energy, mood, sleep quality, cognition, weight distribution, insulin sensitivity, and overall quality of life. Without appropriate medical evaluation, many women are told their symptoms are normal or unrelated to hormonal changes.
Physician‑supervised hormone therapy focuses on determining whether symptoms are hormonally mediated and whether treatment may safely and appropriately improve function and well‑being.
This program may be appropriate for women who:
This program is not appropriate for individuals seeking cosmetic goals, unsupervised hormone use, or guaranteed outcomes.
Patients begin with a brief, no‑obligation call to confirm that LiteWell’s approach aligns with their symptoms, goals, and medical history.
Patients seeking a deeper evaluation complete a comprehensive intake and laboratory assessment. A licensed clinician reviews symptoms, labs, medical history, and goals to develop a personalized clinical strategy.
This focused treatment phase emphasizes symptom improvement, hormonal balance, and metabolic stability.
Long‑term care focuses on sustaining improvement, adjusting therapy as physiology changes, and ongoing safety monitoring.
Hormone therapy is never prescribed automatically and is only considered when appropriate based on medical evaluation and shared decision‑making.
LiteWell operates a hybrid care model that allows women to receive hormone care through telemedicine, in‑person visits at LiteWell convenience clinics, or a combination of both. This approach reduces friction while maintaining clinical oversight.
All care is delivered by licensed clinicians and overseen by physician leadership. Patients are monitored regularly for effectiveness, tolerance, and safety. Medical decisions are individualized and adjusted based on symptoms, laboratory data, and patient experience.
Hormone replacement therapy for women at LiteWell begins with a free Medical Fit Call, followed by a comprehensive intake and laboratory evaluation when clinically appropriate. A licensed clinician evaluates symptoms, medical history, and lab results to determine whether hormone therapy may be appropriate. Treatment plans are individualized and adjusted over time based on response and safety monitoring.
Yes. LiteWell offers hormone replacement therapy for women through a telemedicine‑first model, allowing many evaluations, follow‑ups, and monitoring visits to occur remotely when clinically appropriate. In‑person visits are available at LiteWell convenience clinics for labs, exams, or more comprehensive evaluations. Telemedicine availability depends on state licensure and clinical factors.
Not necessarily. Many women experience symptoms related to hormonal fluctuations during perimenopause. Eligibility for hormone therapy is determined through individualized medical evaluation rather than age alone.
Some hormone therapies prescribed by LiteWell clinicians are FDA‑approved for specific indications. In certain cases, compounded hormone formulations may be prescribed when a clinician determines that a patient has a legitimate medical need that cannot be met by commercially available FDA‑approved products.
Hormone replacement therapy carries both potential benefits and risks. At LiteWell, safety is prioritized through careful screening, shared decision‑making, and ongoing monitoring. Treatment plans are adjusted based on tolerance, laboratory findings, and clinical response.
Hormonal changes can interact with insulin sensitivity, body fat distribution, and metabolic health. Some women receiving hormone therapy may also benefit from coordinated care through LiteWell’s Medical Weight Loss or Longevity & Performance Medicine programs when clinically appropriate.
The first step is a free 10‑minute Medical Fit Call to determine whether physician‑supervised hormone replacement therapy at LiteWell is appropriate for you.
All medical services require appropriate evaluation by a licensed clinician. Treatment plans are individualized, and results vary. No guarantees are made regarding symptom improvement or other outcomes. Telemedicine availability depends on state licensure and clinical appropriateness. LiteWell does not provide emergency care.
LiteWell’s women’s hormone programs may include prescription hormone therapies when clinically appropriate and prescribed by a licensed clinician following medical evaluation.
Some hormone therapies are approved by the U.S. Food and Drug Administration (FDA) for specific indications. In certain cases, compounded hormone medications may be prescribed when a clinician determines that a patient has a legitimate medical need that cannot be met by commercially available FDA‑approved products.
Compounded medications are not FDA‑approved and are not reviewed by the FDA for safety, effectiveness, or quality in the same manner as approved drugs. Compounded formulations may differ in concentration, delivery method, or inactive ingredients.
Medication decisions are individualized, based on medical history, laboratory findings, and shared decision‑making. Not all patients are candidates for hormone therapy, and no specific outcomes are guaranteed.
